Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2023-09-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Transcranial Magnetic Stimulation in the Regulation of Spinocerebellar Ataxia
NCT06904716
Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia
NCT01975909
Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia
NCT04595578
Cerebellar Non-invasive Stimulation in Ataxias
NCT03213106
Cerebellar rTMS for Essential Tremor
NCT02704793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
rTMS with 10 Hz
6 times/per week for 2 weeks, total 12 times rTMS.
Repetitive Transcranial Magnetic Stimulation (rTMS)
6 times/per week for 2 weeks, total 12 times rTMS with 10 Hz.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repetitive Transcranial Magnetic Stimulation (rTMS)
6 times/per week for 2 weeks, total 12 times rTMS with 10 Hz.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* independently walk with/without an assistive device
* SARA greater than 3
Exclusion Criteria
* Unstable blood pressure
* Brain Trauma
* Alcoholism, drug abuse, antipsychotics drug use
* Metallic hardware (e.g. - cochlear implants, brain stimulators or electrodes, aneurysm clips) anywhere in head.
* Dementia, depression
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhua Christian Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sen-yung Liu
Chief Medical Officer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sen Yung Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Changhua Christian Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhua christian hospital
Changhua, , Taiwan
Changhua christian hospital
Changhua, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
230425
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.